Astrana Health, Inc.: 10-Q filed 2015-11-17

Name: Astrana Health, Inc.: 10-Q filed 2015-11-17
Creator: Astrana Health, Inc.

What Astrana Health, Inc. reported in its quarterly report filed 2015-11-17 (fiscal Q2 2016): 35 published measures, 104 facts as tagged in accession 0001144204-15-066403.

This filing

Form: 10-Q (quarterly report)
Filed: 2015-11-17
Fiscal period: fiscal Q2 2016
Accession: 0001144204-15-066403 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Astrana Health, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2015-09-30	13,649,572	USD
At 2015-03-31	14,995,063	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2015-09-30	17,606,771	USD
At 2015-03-31	15,985,247	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2015-09-30	-5,678,671	USD
At 2015-03-31	-2,817,673	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2015-09-30	3,924,922	USD
At 2015-03-31	5,014,242	USD
At 2014-09-30	3,950,125	USD
At 2014-03-31	6,831,478	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-531,366	USD	92
2015-04-01 to 2015-09-30	-3,013,732	USD	183
2014-07-01 to 2014-09-30	1,376,310	USD	92
2014-04-01 to 2014-09-30	-301,431	USD	183

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2015-04-01 to 2015-09-30	42,572	USD	183
2014-04-01 to 2014-09-30	15,583	USD	183

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	11,369,607	USD	92
2015-04-01 to 2015-09-30	21,573,734	USD	183
2014-07-01 to 2014-09-30	11,665,294	USD	92
2014-04-01 to 2014-09-30	15,759,780	USD	183

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2015-09-30	-22,354,252	USD
At 2015-03-31	-19,340,521	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	4,863,389	shares	92
2015-04-01 to 2015-09-30	4,863,389	shares	183
2014-07-01 to 2014-09-30	4,913,455	shares	92
2014-04-01 to 2014-09-30	4,913,455	shares	183

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	4,863,389	shares	92
2015-04-01 to 2015-09-30	4,863,389	shares	183
2014-07-01 to 2014-09-30	5,439,344	shares	92
2014-04-01 to 2014-09-30	4,913,455	shares	183

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-0.11	USD/shares	92
2015-04-01 to 2015-09-30	-0.62	USD/shares	183
2014-07-01 to 2014-09-30	0.28	USD/shares	92
2014-04-01 to 2014-09-30	-0.06	USD/shares	183

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-0.11	USD/shares	92
2015-04-01 to 2015-09-30	-0.62	USD/shares	183
2014-07-01 to 2014-09-30	0.26	USD/shares	92
2014-04-01 to 2014-09-30	-0.06	USD/shares	183

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-186,138	USD	92
2015-04-01 to 2015-09-30	-93,447	USD	183
2014-07-01 to 2014-09-30	86,989	USD	92
2014-04-01 to 2014-09-30	98,591	USD	183

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2015-09-30	577,701	USD
At 2015-03-31	582,470	USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-412,907	USD	92
2015-04-01 to 2015-09-30	-2,077,604	USD	183
2014-07-01 to 2014-09-30	1,858,461	USD	92
2014-04-01 to 2014-09-30	671,877	USD	183

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2015-09-30	8,659,766	USD
At 2015-03-31	9,853,079	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	68,818	USD	92
2015-04-01 to 2015-09-30	429,220	USD	183
2015-04-01 to 2015-06-30	109,949	USD	91
2014-07-01 to 2014-09-30	329,258	USD	92
2014-04-01 to 2014-09-30	606,125	USD	183

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2015-09-30	17,429,427	USD
At 2015-03-31	5,977,712	USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

Period	Value	Unit	Days
At 2015-09-30	2,168,833	USD
At 2015-03-31	2,168,833	USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

Period	Value	Unit	Days
At 2015-03-31	579,163	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2015-09-30	4,015,715	USD
At 2015-03-31	3,801,584	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	11,782,514	USD	92
2015-04-01 to 2015-09-30	23,651,338	USD	183
2014-07-01 to 2014-09-30	9,806,833	USD	92
2014-04-01 to 2014-09-30	15,087,903	USD	183

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2015-09-30	4,863,389	shares
At 2015-03-31	4,863,389	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2015-09-30	16,670,718	USD
At 2015-03-31	16,517,985	USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

Period	Value	Unit	Days
At 2015-09-30	-3,957,199	USD
At 2015-03-31	-990,184	USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2015-09-30	1,283,163	USD
At 2015-03-31	1,377,257	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2015-09-30	212,146	USD
At 2015-03-31	218,716	USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-293,827	USD	92
2015-04-01 to 2015-09-30	-2,524,331	USD	183
2014-07-01 to 2014-09-30	1,535,918	USD	92
2014-04-01 to 2014-09-30	28,384	USD	183

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-531,366	USD	92
2015-04-01 to 2015-09-30	-3,013,732	USD	183
2014-07-01 to 2014-09-30	1,390,809	USD	92
2014-04-01 to 2014-09-30	-268,343	USD	183

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	3,440,641	USD	92
2015-04-01 to 2015-09-30	7,677,846	USD	183
2014-07-01 to 2014-09-30	3,451,907	USD	92
2014-04-01 to 2014-09-30	5,461,239	USD	183

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	77,684	USD	92
2015-04-01 to 2015-09-30	141,435	USD	183
2014-07-01 to 2014-09-30	193,281	USD	92
2014-04-01 to 2014-09-30	205,180	USD	183

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-95,092	USD	92
2015-04-01 to 2015-09-30	5,912	USD	183
2014-07-01 to 2014-09-30	-58,436	USD	92
2014-04-01 to 2014-09-30	-60,912	USD	183

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-67,058	USD	92
2015-04-01 to 2015-09-30	-540,174	USD	183
2014-07-01 to 2014-09-30	-235,554	USD	92
2014-04-01 to 2014-09-30	-544,902	USD	183

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

Period	Value	Unit	Days
2015-04-01 to 2015-09-30	6,129	USD	183
2014-04-01 to 2014-09-30	59,314	USD	183

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2015-04-01 to 2015-09-30	214,131	USD	183
2014-04-01 to 2014-09-30	993,669	USD	183

Inspect the source

Entity: Astrana Health, Inc. / CIK 0001083446
Captured: 2026-09-20T05:20:50.832Z
SEC response SHA-256: 24589a8b90ad6a7cdaab8fd1b252b61b042f4e45ec87312920857f7a3d1d7dfe

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001083446.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))